(Total Views: 417)
Posted On: 02/13/2021 10:52:56 AM
Post# of 148899
“Has anyone rebutted Midas letter analysis. Of what he calls teh downside risk to cydy?”
Don’t waste your time. CYDY has been accepting poor financing deals for years because they’re a small biotech without revenue. This Midas letter is pointing out the obvious, what we all as investors already know.
Don’t waste your time. CYDY has been accepting poor financing deals for years because they’re a small biotech without revenue. This Midas letter is pointing out the obvious, what we all as investors already know.
(8)
(0)Scroll down for more posts ▼
